Exelon Corporation Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Exelon Corporation on March 23, 2016. The report details the completion of a previously announced acquisition of Pepco Holdings, Inc. (PHI) through a merger with Purple Acquisition Corp., an indirect, wholly-owned subsidiary of Exelon. The transaction became effective at 4:58 pm Eastern Daylight Time on the Closing Date.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period. The primary financial metric disclosed is the transaction consideration:
- Acquisition Price: $27.25 per share in cash, without interest, for each outstanding share of PHI common stock (excluding Excluded Shares).
- Stock Delisting: PHI common stock (symbol "POM") ceased trading and was delisted from the New York Stock Exchange effective at the opening of trading on the Closing Date.
Material Changes
The material change reported is the structural consolidation of PHI into Exelon. As of the Effective Time:
- PHI became an indirect, wholly-owned subsidiary of Exelon.
- All PHI shares ceased to be outstanding and were cancelled, converting into the right to receive the cash consideration.
- Shares held by Dissenting Stockholders retain the right to seek appraisal payments under Section 262 of the Delaware General Corporation Law.
Guidance, Outlook, and Risks
The filing contains forward-looking statements subject to risks and uncertainties. Management directs readers to Exelon's 2015 Annual Report on Form 10-K (specifically Item 1A Risk Factors, Item 7 MD&A, and Item 8 Note 23) for a discussion of factors that could cause actual results to differ materially from expectations. Exelon explicitly states it does not undertake any obligation to publicly release revisions to these forward-looking statements.
Investor Verification Checklist
- Verify the final cash consideration of $27.25 per share received by PHI shareholders.
- Confirm the delisting of PHI stock (POM) from the NYSE.
- Review the full text of the Amended and Restated Agreement and Plan of Merger (Exhibit 2.1) for specific terms and conditions.
- Consult the joint press release (Exhibit 99.1) for immediate post-merger operational details.
- Check Exelon's 2015 Form 10-K for updated risk factors and financial projections related to the integration of PHI.